Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Some providers extend the time at each dose level to two months instead of one, especially when transitioning to higher doses
Researchers benefit from competitive pricing that doesnt compromise quality standards, so institutions can maintain research budgets while getting high quality compounds
It should not be used as a drug or injection, since the FDA has not approved it for human use
You choose
(October 18, 2025) Evaluation of Polmacoxib 2 mg for the Management of Hip and Knee Osteoarthritis: A Prospective, Single-Arm, Multicenter, Open-Label Study
Reference: Malinda KM et al
US$ 29.83
US$ 25.00
US$ 27.73
US$ 27.35
US$ 28.54
